Shares of Moderna Inc. MRNA, +4.79% rose 4.79% to $416.70 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP, +0.21% rising 0.21% to 15,363.52 and the Dow Jones Industrial Average DJIA, -0.21% falling 0.21% to 35,369.09. This was the stock’s fourth consecutive day of gains. Moderna Inc. closed $80.79 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock outperformed some of its competitors Friday, as AbbVie Inc. ABBV, -0.36% fell 0.36% to $111.62, Amgen Inc. AMGN, +0.18% rose 0.18% to $226.37, and AstraZeneca PLC ADR AZN, -1.28% fell 1.28% to $58.83. Trading volume (13.8 M) remained 5.6 million below its 50-day average volume of 19.4 M.